Navigation Links
Control of blood vessels a possible weapon against obesity
Date:1/7/2009

[PRESS RELEASE, 7 January 2009] Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes.

The growth of fat cells and their metabolism depend on oxygen and blood-borne nutrients. A possible way to regulate the amount of body fat in order, for instance, to combat obesity can therefore be to affect the development of blood vessels in the adipose tissue.

A team of researchers at Karolinska Institutet have now demonstrated the rapid development of blood vessels in the adipose tissue of mice exposed to low temperatures. This is followed in its turn by a transformation of the adipose tissue from 'white' fat to 'brown' fat, which has higher metabolic activity and which breaks down more quickly.

"This is the first time it's been shown that blood vessel growth affects the metabolic activity of adipose tissue rather than vice versa," says Professor Yihai Cao, who led the study. "If we can learn how to regulate the development of blood vessels in humans, we'd open up new therapeutic avenues for obesity and metabolic diseases like diabetes."

Brown fat releases heat when it breaks down, and is mainly found in hibernating animals. In humans, it is found in newborn babies, but scientists believe by controlling blood vessel development that it might be possible to transform white fat to brown fat in adults as well.


'/>"/>

Contact: KI Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Source:Eurekalert

Page: 1

Related biology news :

1. Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial
2. Organic plant waste proves effective weed control for citrus trees
3. Motor nerve targeting to limb muscles is controlled by ephrin proteins
4. New satellite data reveal impact of Olympic pollution controls
5. Brain enzyme may play key role in controlling appetite and weight gain
6. Fractional dose of scarce meningitis vaccine may be effective in outbreak control
7. New control knobs for stem cells identified
8. Cool idea for efficient climate control wins recognition
9. A scientific breakthrough on the control of the bad cholesterol
10. Futronic Launches FS22 Fingerprint Access Control Device
11. New insight into the controls on a go-to enzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology: